[1] Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent 2022;2(1):1 − 9. http://dx.doi.org/10.1016/j.jncc.2022.02.002CrossRef
[2] Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine 2021;38:100985. http://dx.doi.org/10.1016/j.eclinm.2021.100985CrossRef
[3] Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health 2020;8(8):e1027 − 37. http://dx.doi.org/10.1016/s2214-109x(20)30215-1CrossRef
[4] Lei SY, Zheng RS, Zhang SW, Chen R, Wang SM, Sun KX, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med 2021;18(3):900 − 9. http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0523CrossRef
[5] Li N, Deng YJ, Zhou LH, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol 2019;12(1):140. http://dx.doi.org/10.1186/s13045-019-0828-0CrossRef
[6] Luan HH, Luo LS, Lu ZY. Historical trends in incidence of breast cancer in Shanghai, Hong Kong and Los Angeles, 1973-2012: a joinpoint and age-period-cohort analysis. Int J Public Health 2021;66:603810. http://dx.doi.org/10.3389/ijph.2021.603810CrossRef
[7] Yadav S, LaDuca H, Polley EC, Hu CL, Niguidula N, Shimelis H, et al. Racial and ethnic differences in multigene hereditary cancer panel test results for women with breast cancer. J Natl Cancer Inst 2021;113(10):1429 − 33. http://dx.doi.org/10.1093/jnci/djaa167CrossRef
[8] Ding YN, Chen XG, Zhang QJ, Liu Q. Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990-2015 breast Cancer mortality data. BMC Public Health 2020;20(1):1280. http://dx.doi.org/10.1186/s12889-020-09375-0CrossRef
[9] Wang JY, Lv HZ, Xue ZL, Wang L, Bai ZQ. Temporal trends of common female malignances on breast, cervical, and ovarian cancer mortality in Japan, Republic of Korea, and Singapore: application of the age-period-cohort model. Biomed Res Int 2018;2018:5307459. http://dx.doi.org/10.1155/2018/5307459CrossRef
[10] Mubarik S, Shakil Malik S, Wang ZK, Li CH, Fawad M, Yu CH. Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model. Cancer Manag Res 2019;11:8145 − 55. http://dx.doi.org/10.2147/cmar.S208323CrossRef
[11] Krishnamoorthy Y, Rajaa S, Giriyappa DK, Bharathi A, Velmurugan B, Ganesh K. Worldwide trends in breast cancer incidence from 1993 to 2012: age-period-cohort analysis and joinpoint regression. J Res Med Sci 2020;25:98. http://dx.doi.org/10.4103/jrms.JRMS_708_19CrossRef
[12] Wang YC, Lin CH, Huang SP, Chen M, Lee TS. Risk factors for female breast cancer: a population cohort study. Cancers (Basel) 2022;14(3):788. http://dx.doi.org/10.3390/cancers14030788CrossRef
[13] Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev 2016;49:65 − 76. http://dx.doi.org/10.1016/j.ctrv.2016.07.006CrossRef
[14] Chen WQ, Xia CF, Zheng RS, Zhou MG, Lin CQ, Zeng HM, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health 2019;7(2):e257 − 69. http://dx.doi.org/10.1016/s2214-109x(18)30488-1CrossRef
[15] Zeng HM, Ran XH, An L, Zheng RS, Zhang SW, Ji JS, et al. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. Lancet Public Health 2021;6(12):e877 − 87. http://dx.doi.org/10.1016/s2468-2667(21)00157-2CrossRef